A team has identified an experimental molecule capable of “reprogramming” the brain’s immune cells to restore part of their protective function against Alzheimer’s disease. The study, published in the journal Cell Death and Disease, shows that the compound, called OLE, helps microglia enclose and contain beta-amyloid plaques, reducing their size and toxicity.
If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.
If you want to read more Like this articles, you can visit our Science category.